Let’s start up with the current stock price of Abeona Therapeutics Inc. (ABEO), which is $1.77 to be very precise. The Stock rose vividly during the last session to $1.80 after opening rate of $1.638 while the lowest price it went was recorded $1.61 before closing at $1.68.
Recently in News on April 20, 2021, Abeona Therapeutics Announces Presentation on New Preclinical Data Supporting the Potential of Cre-Mediated Dual AAV Vector Technology to Enable Delivery of Large Genes Targeted for Treatment of Stargardt Disease at ARVO 2021 Annual Meeting. Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that new data from its preclinical research will be highlighted during an oral presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting, being held virtually from May 1-7, 2021. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Abeona Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.7899 on 02/09/21, with the lowest value was $1.3550 for the same time period, recorded on 04/19/21.
Abeona Therapeutics Inc. (ABEO) full year performance was -25.63%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Abeona Therapeutics Inc. shares are logging -53.30% during the 52-week period from high price, and 78.88% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.99 and $3.79.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2020453 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Abeona Therapeutics Inc. (ABEO) recorded performance in the market was 12.74%, having the revenues showcasing -7.33% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 166.40M, as it employees total of 76 workers.
Specialists analysis on Abeona Therapeutics Inc. (ABEO)
During the last month, 0 analysts gave the Abeona Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.9718, with a change in the price was noted +0.2600. In a similar fashion, Abeona Therapeutics Inc. posted a movement of +17.22% for the period of last 100 days, recording 3,287,633 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ABEO is recording 0.02 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
Trends and Technical analysis: Abeona Therapeutics Inc. (ABEO)
Raw Stochastic average of Abeona Therapeutics Inc. in the period of last 50 days is set at 27.39%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 80.60%. In the last 20 days, the company’s Stochastic %K was 60.46% and its Stochastic %D was recorded 54.26%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 12.74%. Additionally, trading for the stock in the period of the last six months notably improved by 62.39%, alongside a downfall of -25.63% for the period of the last 12 months. The shares increased approximately by 9.26% in the 7-day charts and went up by -5.85% in the period of the last 30 days. Common stock shares were lifted by -7.33% during last recorded quarter.